Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Boehringer Ingelheim
Merck
McKesson
Moodys

Last Updated: June 26, 2022

Lorazepam - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

What are the generic sources for lorazepam and what is the scope of freedom to operate?

Lorazepam is the generic ingredient in six branded drugs marketed by Almatica, Akorn, Amneal Pharms, Lannett Co Inc, Lupin Ltd, Pharm Assoc, Hikma, Bedford, Dava Pharms Inc, Dr Reddys, Hospira, Intl Medication Sys, Rising, Watson Labs, Bedford Labs, Roxane, Bausch, Quantum Pharmics, Am Therap, Anda Repository, Ani Pharms, Aurolife Pharma Llc, Halsey, Leading Pharma Llc, Mutual Pharm, Mylan, Oxford Pharms, Par Pharm, Sandoz, Sun Pharm Inds Ltd, Superpharm, Usl Pharma, and Warner Chilcott, and is included in seventy NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Lorazepam has thirty-four patent family members in twenty-nine countries.

There are eleven drug master file entries for lorazepam. Thirty-five suppliers are listed for this compound.

Drug Prices for lorazepam

See drug prices for lorazepam

Drug Sales Revenue Trends for lorazepam

See drug sales revenues for lorazepam

Recent Clinical Trials for lorazepam

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Northwell HealthEarly Phase 1
Pontificia Universidad Catolica de ChileN/A
Jayasree BasivireddyPhase 3

See all lorazepam clinical trials

Pharmacology for lorazepam
Drug ClassBenzodiazepine
Medical Subject Heading (MeSH) Categories for lorazepam
Anatomical Therapeutic Chemical (ATC) Classes for lorazepam

US Patents and Regulatory Information for lorazepam

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan LORAZEPAM lorazepam TABLET;ORAL 071591-001 Oct 13, 1987 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Watson Labs LORAZEPAM lorazepam INJECTABLE;INJECTION 074276-001 Apr 15, 1994 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Am Therap LORAZEPAM lorazepam TABLET;ORAL 070727-001 Mar 7, 1986 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for lorazepam

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Hikma ATIVAN lorazepam INJECTABLE;INJECTION 018140-001 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Hikma ATIVAN lorazepam INJECTABLE;INJECTION 018140-002 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for lorazepam

Country Patent Number Title Estimated Expiration
World Intellectual Property Organization (WIPO) 2014110245 See Plans and Pricing
Singapore 11201505349R SUSTAINED RELEASE FORMULATIONS OF LORAZEPAM See Plans and Pricing
Mexico 2015008756 FORMULACIONES DE LORAZEPAM DE LIBERACION SOSTENIDA. (SUSTAINED RELEASE FORMULATIONS OF LORAZEPAM.) See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Dow
AstraZeneca
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.